Research ArticleClinical Studies

Methylenetetrahydrofolate Reductase and Thymidylate Synthase Polymorphisms are not Associated with Breast Cancer Risk or Phenotype

FABIENNE GRIEU, BRENDA POWELL, JOHN BEILBY and BARRY IACOPETTA
Anticancer Research September 2004, 24 (5B) 3215-3220;

Article Information

vol. 24 no. 5B 3215-3220
PMID 
15510613
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 23, 2004
  • Accepted July 30, 2004
  • Published online September 1, 2004.
Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. FABIENNE GRIEU1,
  2. BRENDA POWELL2,
  3. JOHN BEILBY3 and
  4. BARRY IACOPETTA2
  1. 1Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands 6009
  2. 2School of Surgery and Pathology, University of Western Australia, Crawley 6009
  3. 3Clinical Biochemistry, PathCentre, Sir Charles Gairdner Hospital, Nedlands 6009, Australia
  1. Correspondence to: A/Prof. Barry Iacopetta, School of Surgery and Pathology M507, University of Western Australia, 35 Stirling Hwy, Crawley 6009, Australia. e-mail: bjiac{at}cyllene.uwa.edu.au

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Methylenetetrahydrofolate Reductase and Thymidylate Synthase Polymorphisms are not Associated with Breast Cancer Risk or Phenotype
FABIENNE GRIEU, BRENDA POWELL, JOHN BEILBY, BARRY IACOPETTA
Anticancer Research Sep 2004, 24 (5B) 3215-3220;
Twitter logo Facebook logo Mendeley logo

Jump to section